# PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
> **NDA206056** · New Drug Application · Sponsor: B BRAUN MEDICAL · Approved 2025-04-03
## Drug
- **FDA Application Number:** NDA206056
- **Application type:** New Drug Application
- **Brand name:** PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
- **Generic name:** PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE
- **Active ingredients:** PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** B BRAUN MEDICAL
- **Manufacturer:** B. Braun Medical Inc.
- **First approval:** 2025-04-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206056)
---
*MORVS · CC0 1.0*